Drug-approval pace remains brisk in 1997

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:336 / 336
页数:1
相关论文
共 50 条
  • [41] Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations
    Xian, Wenyan
    Tao, Yifan
    You, Chong
    Sun, Ruinan
    Ranson, Janice M.
    Napolioni, Valerio
    Lau, Patrick W. C.
    Huang, Jie
    THROMBOSIS AND HAEMOSTASIS, 2025,
  • [43] Drug approval in Europe
    Walsh G.
    Nature Biotechnology, 1999, 17 (3) : 237 - 240
  • [44] NEW DRUG APPROVAL
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2009, 109 (10) : 32 - 32
  • [45] The Accelerated Drug Approval
    Novack, Gary D.
    OCULAR SURFACE, 2010, 8 (04): : 205 - 206
  • [46] The drug approval tactician
    Frantz, S
    NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (09) : 757 - 757
  • [47] Drug approval in Europe
    Walsh, Gary
    Nature Biotechnology, 1999, 17 (03):
  • [48] FDA and drug approval
    Faich, GA
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (06) : S24 - S24
  • [49] The drug approval tactician
    Simon Frantz
    Nature Reviews Drug Discovery, 2003, 2 : 757 - 757
  • [50] Drug approval times
    Lexchin, J
    Mintzes, B
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 162 (13) : 1803 - 1804